Baylor and Rice Receive $2.3 Million to Develop Antibody Therapy for Metastatic Breast Cancer
December 05, 2024
December 05, 2024
HOUSTON, Texas, Dec. 5 (TNSres) -- The Baylor College of Medicine issued the following news:
Researchers at Baylor College of Medicine and Rice University have received a $2.3 million Breakthrough Award from the Department of Defense Congressionally Directed Medical Research Programs to develop a novel NanoGel antibody therapy that targets ER+ breast cancer that has metastasized to bone.
"Current treatments work well for ER+ breast cancer, but 20-40% of survivors . . .
Researchers at Baylor College of Medicine and Rice University have received a $2.3 million Breakthrough Award from the Department of Defense Congressionally Directed Medical Research Programs to develop a novel NanoGel antibody therapy that targets ER+ breast cancer that has metastasized to bone.
"Current treatments work well for ER+ breast cancer, but 20-40% of survivors . . .